COVID-19 Resources

As we all work to navigate the impact of COVID-19 on the health care sector and how care is delivered, ASPL wants to ensure our members have access to valuable resources to help you manage guidance being issued related to this pandemic.  If your organization has resources it would like to share, please forward the information to [email protected].

Bula Intelligence - Bula Blog
Faegre Drinker - Coronavirus (COVID-19) Resource Center
Hall Render - COVID-19 Resource Center
Quarles & Brady - COVID-19: Guidance for Clients

 

 

The American Society for Pharmacy Law (ASPL) is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties.

ASPL is a nonprofit organization with the purposes of

  • Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues;
  • Communicating accurate legal educational information; and
  • Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law

Latest News

March 23, 2020

COVID-19
Ohio Board of Pharmacy restricts dispensing of chloroquine and hydroxychloroquine for treatment of COVID-19 infections

On March 22, the Ohio Board of Pharmacy filed emergency rule 4729-5-30.2, OAC. The rule sets specific requirements for dispensing prescriptions for chloroquine or hydroxychloroquine. Unless otherwise approved by the executive director of the Board, no prescription for hydroxychloroquine or chloroquine may be dispensed unless the prescription includes a written diagnosis code from the prescriber. If the diagnosis code is for COVID-19, the prescriber must document that the diagnosis has been confirmed by a positive test result and the prescription is limited to a 14-day supply. Such prescriptions are not refillable.

Prescriptions for either presumptive positive patients or prophylactic use of the drugs related to COVID-19 are prohibited, unless approved by the executive director in consultation with the Board president. The announcement includes FAQs. [State of Ohio, Board of Pharmacy. Emergency Rule for Dispensing Chloroquine and Hydroxychloroquine, March 22, 2020; https://bit.ly/33DNb4S